G Schieppati
Overview
Explore the profile of G Schieppati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomirotti M, Bernardo G, Epifani C, Biasioli R, Franchi R, Mensi F, et al.
Int J Oncol
. 2011 May;
3(2):213-7.
PMID: 21573350
Thirty-one patients with metastatic breast cancer not responding or progressing after initial response to adriamycin + cyclophosphamide (AC) treatment entered a phase 11 study with oral lonidamine in association to...
2.
Bajetta E, Buzzoni R, Mariani L, Beretta E, Bozzetti F, Bordogna G, et al.
Ann Oncol
. 2002 Mar;
13(2):299-307.
PMID: 11886009
Background: The aim of this study was to determine the efficacy of the EAP regimen (etoposide, adriamycin and cisplatin) followed by the Machover schedule (fluorouracil and folinic acid) given as...
3.
Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Romeo D, Caroti C, et al.
J Clin Oncol
. 2001 Nov;
19(22):4209-15.
PMID: 11709564
Purpose: To determine whether switching patients from tamoxifen to antiaromatase treatment would prevent some of the relapses or deaths that we assume would occur if tamoxifen were continued. Patients And...
4.
Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Pacini P, Gallo L, et al.
Recent Results Cancer Res
. 1999 Feb;
152:453-70.
PMID: 9928580
The first GROCTA trial compared 5-year tamoxifen treatment to ten chemotherapy cycles in a group of 504 pre-/post-menopausal, node-positive, ER-positive breast cancer patients. This study also included an arm combining...
5.
Bajetta E, Di Bartolomeo M, Carnaghi C, Buzzoni R, Mariani L, Gebbia V, et al.
Br J Cancer
. 1998 May;
77(7):1149-54.
PMID: 9569054
The new regimens developed over the last few years have led to an improvement in the treatment of advanced gastric cancer, and our previous experience confirmed the fact that the...
6.
Bajetta E, Zilembo N, Barni S, Noberasco C, Martinetti A, Ferrari L, et al.
Ann Oncol
. 1997 Jul;
8(7):649-54.
PMID: 9296217
Background: In postmenopausal breast cancer (BC) patients, tamoxifen (TAM) is frequently used in first-line therapy, and for those relapsing under TAM, aromatase inhibitors would be the drug of choice. Formestane,...
7.
Saccardo F, Monti G, Reina F, Schieppati G, Invernizzi F
Ann Ital Med Int
. 1992 Jul;
7(3):171-5.
PMID: 1457257
We discuss the cases of two patients affected with chronic eosinophilic pneumonia (CEP) pleurisy and eosinophilia in pleural effusion, not previously mentioned in the literature, to point out their peculiarity,...
8.
Ambrosini G, Balli M, Garusi G, Demicheli R, Jirillo A, Bonciarelli G, et al.
J Clin Oncol
. 1988 Jun;
6(6):976-82.
PMID: 2897433
From February 1983 to January 1985, 497 patients with advanced breast cancer were randomly allocated to receive either epirubicin or doxorubicin in the following combination chemotherapy regimen: fluorouracil (5-FU) 500...
9.
Reguzzoni G, Schieppati G, Stagni F, Lampertico P
Pathologica
. 1985 May;
77(1049):337-46.
PMID: 3831884
No abstract available.
10.
Garelli S, Schieppati G, Banfi L, Meroni P
Tumori
. 1983 Oct;
69(5):409-15.
PMID: 6649068
A study of some aspects of granulocyte function was carried out before, during, and after cyclic chemotherapy in 9 patients surgically treated for carcinoma and in 6 patients with very...